Vol 43, No 4 (2012)
Untitled
Published online: 2012-10-01

open access

Page views 171
Article views/downloads 165
Get Citation

Connect on Social Media

Connect on Social Media

Analysis of ex vivo Apoptosis of B and T cells from Peripheral Blood and Bone Marrow of Patients with Chronic Lymphocytic Leukemia

Agnieszka Bojarska-Junak1, Iwona Hus2, Karolina Olszewska-Bożek1, Sylwia Chocholska2, Ewa Wąsik-Szczepanek2, Waldemar Tomczak2, Justyna Miłczak3, Anna Dmoszyńska2, Jacek Roliński1
DOI: 10.1016/S0001-5814(12)70005-1
Acta Haematol Pol 2012;43(4):336-341.

Abstract

In this study we analyzed selected parameters of apoptosis in leukemic cells from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia (CLL). The percentage of apoptotic leukemic B cells (Δψmlow/CD19+) was significantly lower in peripheral blood (median: 0.99%) than in bone marrow (median: 1.41%) (p<0.0001). These data can support the idea that these two compartments might have different proliferative statuses. There was an inverse correlation between the ex vivo percentage of apoptotic cells and lymphocytosis (R=-0.34; p<0.01), and a direct correlation between the percentage of PB apoptotic B cells and the Rai stage (R=0.42; p<0.05). The percentage of Δψmlow/CD19+ cells was significantly higher in ZAP-70-positive patients than from ZAP-70-negative patients (p<0.01). There was also a significant difference in the median percentage of apoptotic leukemic B cells between the patients carrying del(11q22.3) or/and del(17p13.1) (2.7%) and the patients without these unfavorable genetic aberrations (1.6%) (p<0.01). The B cells from ZAP-70-positive patients with more aggressive disease seem to be more susceptible to spontaneous apoptosis than those from ZAP-70-negative patients. We conclude that the evaluation of ex vivo apoptosis might provide new important information concerning the biology and prognosis of CLL.

Article available in PDF format

View PDF Download PDF file